Reaching for wellness in schizophrenia

Deanna L Kelly1, Douglas L Boggs, Robert R Conley

  • 1Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA. dkelly@mprc.umaryland.edu <dkelly@mprc.umaryland.edu>

Insights

Coronary heart disease (CHD) is a leading cause of death for individuals with schizophrenia. Addressing modifiable risk factors like smoking and hypertension is crucial for improving long-term health outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Coronary heart disease (CHD) is a significant cause of mortality in schizophrenia patients.
  • Multiple factors contribute to CHD in this population, including lifestyle, antipsychotic medications, and comorbidities.
  • Certain modifiable risk factors are more prevalent in schizophrenia patients compared to the general population.

Purpose of the Study:

  • To review and highlight the modifiable risk factors for coronary heart disease (CHD) in patients with schizophrenia.
  • To emphasize the increased frequency of these risk factors in individuals with schizophrenia.
  • To advocate for improved management of these risk factors to enhance patient outcomes.

Main Methods:

  • Literature review focusing on modifiable risk factors for CHD in schizophrenia.
  • Analysis of the prevalence of specific risk factors (smoking, diabetes, hyperlipidemia, hypertension, metabolic syndrome) in schizophrenia patients.
  • Discussion of treatment challenges and recommendations.

Main Results:

  • Schizophrenia patients exhibit higher rates of cigarette smoking, diabetes, hyperlipidemia, hypertension, and metabolic syndrome.
  • These factors significantly contribute to the elevated CHD mortality in this population.
  • Current treatment of these risk factors remains suboptimal.

Conclusions:

  • Managing modifiable risk factors is essential for improving the long-term prognosis of schizophrenia patients.
  • Aggressive management of smoking, diabetes, hypertension, and hyperlipidemia is necessary.
  • Efforts to promote wellness and optimal risk factor control are critical.

Related Concept Videos

Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Stress Prevention and Stress Management Techniques VI01:30

Stress Prevention and Stress Management Techniques VI

Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...